(40 days)
Not Found
Not Found
No
The device description and performance studies focus on the physical properties and sterilization efficacy of a pouch, with no mention of AI/ML technologies.
No
The device is intended to enclose medical devices for sterilization and maintain their sterility, and optionally to monitor the sterilization process parameters. It does not directly provide therapy to a patient.
No
The device is a pouch for sterilizing other medical devices, and the integrated chemical process indicator monitors sterilization parameters, not a biological state or disease.
No
The device is a physical pouch made of paper and plastic film, intended for sterilizing and maintaining the sterility of other medical devices. It is a hardware device, not software.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states the device is for enclosing other medical devices for sterilization and maintaining sterility. It does not mention any use in the examination of specimens derived from the human body for the purpose of providing information for diagnosis, monitoring, or compatibility testing.
- Device Description: The description focuses on the physical construction of the pouch and the chemical indicator, not on any components or processes related to analyzing biological samples.
- Lack of IVD-related terms: The text does not contain any terms typically associated with IVD devices, such as "specimen," "sample," "analyte," "diagnosis," "monitoring," "assay," etc.
The device is a sterilization pouch and a chemical process indicator, both of which are considered medical devices but fall under different regulatory categories than IVDs.
N/A
Intended Use / Indications for Use
The REXAM Fracture Resistant Pouch is a device intended to be used to enclose another medical device that is to be steam or ethylene oxide sterilized by a health care provider. It is intended to allow sterilization of the enclosed medical device and also to maintain sterility of the enclosed device until its use.
The chemical process indicator on the REXAM Fracture Resistant Pouch is a device intended for use by a health care provider to accompany products being sterilized through a sterilization procedure and to monitor one or more parameters of the sterilization process. The adequacy of the sterilization of the sterilization conditions as measures by these parameters is indicated by a visible change in the device.
Product codes (comma separated list FDA assigned to the subject device)
KCT
Device Description
The predicate device and the REXAM Fracture Resistant Pouch are constructed of sterilizable kraft paper sealed to the polypropylene surface of a polyester-polypropylene plastic film lamination. Three sides of the pouch are sealed during manufacture. There are two versions of the REXAM Fracture Resistant Pouch: (1) a final heat seal closure of the paper and plastic film laminate components, and (2) a final self-seal closure employing a pressure sensitive self-seal tape assembled on the paper component and sealed to the polyester layer of the plastic film laminate. Both types of final closures are applied by the health care provider.
A chemical sterilization process indicator for steam or ethylene oxide sterilization, or both, may be incorporated to monitor exposure to the sterilant.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
health care provider
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The performance of the REXAM Fracture Resistant Pouch was measured by film properties, seal strength, and film fracture rate pre-sterilization and post-sterilization, 270°F pre-vacuum steam and 100% ethylene oxide. All analyses were performed at a 95% confidence level, and the results illustrate equivalent plastic film laminate tensile and puncture properties, and sterilization pouch seal strengths. The REXAM Fracture Resistant Pouch differs technologically from the predicate sterilization pouch by providing a minimum of a 10 fold reduction in plastic film laminate fracture during peel-open. Through U.S. Pharmacopeia Agar Diffusion and Elution Testing, the plastic film lamination is proven to be safe.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Not Found
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 880.6850 Sterilization wrap.
(a)
Identification. A sterilization wrap (pack, sterilization wrapper, bag, or accessories, is a device intended to be used to enclose another medical device that is to be sterilized by a health care provider. It is intended to allow sterilization of the enclosed medical device and also to maintain sterility of the enclosed device until used.(b)
Classification. Class II (performance standards).
0
REXAM
510(k) Summary
This 510(k) summary information is being submitted in accordance with the requirements of the Safe Medical Device Act of 1990 and 21 CFR 807.92.
The assigned 510(k) number is:
Applicant Information:
| Name: | REXAM Medical Packaging |
|---|---|
| Address: | 1919 S. Butterfield Road |
| Mundelein, IL 60060-9735 | |
| Contact Person: | Denis G. Dyke |
| V.P., Quality and Regulatory Affairs | |
| Phone Number: | (847) 918-4606 |
| FAX Number: | (847) 362-1848 |
| Date Prepared: | September 9, 1997 |
Device Information:
| Trade Name: | REXAM Fracture Resistant Pouch |
|---|---|
| Common Name: | Sterilization Pouch with or without Chemical |
| Sterilization Process Indicator | |
| Classification Name: | Sterilization Wrap, Chemical Sterilization Process Indicator |
Predicate Device:
| Trade Name: | Registered trademark of REXAM Medical Packaging:
REXAM INTEGRA® Pack and OptiPeel® |
|---------------|---------------------------------------------------------------------------------------|
| | Registered trademark of Allegiance Healthcare Corp. |
| | DualPeel® |
| Manufacturer: | REXAM Medical Packaging |
Device Description:
The predicate device and the REXAM Fracture Resistant Pouch are constructed of sterilizable kraft paper sealed to the polypropylene surface of a polyester-polypropylene plastic film lamination. Three sides
1
REXAM
of the pouch are sealed during manufacture. There are two versions of the REXAM Fracture Resistant Pouch: (1) a final heat seal closure of the paper and plastic film laminate components, and (2) a final self-seal closure employing a pressure sensitive self-seal tape assembled on the paper component and sealed to the polyester layer of the plastic film laminate. Both types of final closures are applied by the health care provider.
A chemical sterilization process indicator for steam or ethylene oxide sterilization, or both, may be incorporated to monitor exposure to the sterilant.
Intended Use:
The REXAM Fracture Resistant Pouch is a device intended to be used to enclose another medical device that is to be steam or ethylene oxide sterilized by a health care provider. It is intended to allow sterilization of the enclosed medical device and also to maintain sterility of the enclosed device until its use.
The chemical process indicator on the REXAM Fracture Resistant Pouch is a device intended for use by a health care provider to accompany products being sterilized through a sterilization procedure and to monitor one or more parameters of the sterilization process. The adequacy of the sterilization of the sterilization conditions as measures by these parameters is indicated by a visible change in the device.
Comparison of Technological Characteristics:
Sterilization pouches for gaseous-type sterilization are typically composed of a porous microbial barrier such as paper and a transparent, plastic film laminate. The plastic film laminate is typically composed of a polyester film component adhesively laminated to a polypropylene film component.
The REXAM Fracture Resistant Pouch has the same intended use as the
2
REXAM
REXAM MEDICAL PACKAGING 1919 S BUTTERFIELD ROAD MUNDELEIN IL 60060 USA FAX 1 847 362 1848 1 847 362 9000
predicate sterilization pouch but differs technologically through the use of a new polypropylene film component in the plastic film laminate. This improved component reduces fracture resistance upon pouch peel-open. All other components as well as the sterilization pouch and plastic film laminate method of manufacture are identical.
The performance of the REXAM Fracture Resistant Pouch was measured by film properties, seal strength, and film fracture rate pre-sterilization and post-sterilization, 270°F pre-vacuum steam and 100% ethylene oxide. All analyses were performed at a 95% confidence level, and the results illustrate equivalent plastic film laminate tensile and puncture properties, and sterilization pouch seal strengths. The REXAM Fracture Resistant Pouch differs technologically from the predicate sterilization pouch by providing a minimum of a 10 fold reduction in plastic film laminate fracture during peel-open. Through U.S. Pharmacopeia Agar Diffusion and Elution Testing, the plastic film lamination is proven to be safe.
The polypropylene film component change within the plastic film laminate produces an substantially equivalent sterilization pouch with a technological improvement in film fracture resistance upon opening that is safe and effective.
3
Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with three heads facing to the right. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" are arranged in a circular pattern around the eagle.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20856
OCT 20 1997
Ms. Andrea Haferkamp Quality and Requlatory Manaqer Rexam Medical Packaging 1919 South Butterfield Road Mundelein, Illinois 60060-9735
Re: K973440 Trade Name: Rexam Fracture Resistant Pouch Requlatory Class: II Product Code: KCT Dated: September 9, 1997 Received: September 10, 1997
Dear Ms. Haferkamp:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Druq, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual reqistration, listing of devices, good manufacturing practice, labeling, and prohibitions aqainst misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Druq Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in requlatory action. In addition, FDA may publish further announcements concerning your device in the Federal Reqister. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531
4
Page 2 - Ms. Haferkamp
through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
This letter will allow you to begin marketing vour device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labelinq regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4618. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to
premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours,
Timothy A Ulatowski Director Division of Dental, Infection Control and General Hospital Devices Office of Device Evaluation Center for Devices and Radiological Health
. Enclosure
5
510(k) Number (if known): Device Name: REXAM Fracture Resistant Pouch
Indications For Use:
The REXAM Fracture Resistant Pouch is a device intended to be used to enclose another medical device that is to be sterilized by a health care provider. It is intended to allow sterilization of the enclosed medical device and also to maintain sterility of the enclosed device until used.
The chemical process indicator on the REXAM Fracture Resistant Pouch is a device intended for use by a health care provider to accompany products being sterilized through a sterilization procedure and to monitor one or more parameters of the sterilization process. The adequacy of the sterilization conditions as measured by these parameters is indicated by a visible change in the device.
oncurrence of CDRH, Office of Device Evaluation (ODE)
Qian S. Lam
510(k) Num
Prescription Use
Over-The-Counter-Use OR